Acute FGF21 treatment suppressed hepatic glucose production, increased liver glycogen, lowered glucagon and improved glucose clearance in ob/+ mice, while chronic FGF21 treatment ameliorated fasting hyperglycaemia in ob/ob mice via increased glucose disposal and improved hepatic insulin sensitivity 19. This evidence concerns the gene FGF21 and Hyperglycemia.